Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


15.04.2019

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
1 Am J Clin Oncol
2 BMC Cancer
1 Br J Neurosurg
2 Clin Neuropathol
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
8 J Neurooncol
3 Neuro Oncol
1 Oncogene
2 Pediatr Hematol Oncol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. SILVEIRA AB, Kasper LH, Fan Y, Jin H, et al
    Correction to: H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo.
    Acta Neuropathol. 2019 Apr 11. pii: 10.1007/s00401-019-02006.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. DASGUPTA A, Gupta T
    Radiogenomics in Medulloblastoma: Can the Human Brain Compete with Artificial Intelligence and Machine Learning?
    AJNR Am J Neuroradiol. 2019 Apr 11. pii: ajnr.A6040. doi: 10.3174/ajnr.A6040.
    PubMed     Text format    


    Am J Clin Oncol

  3. PALMER JD, Bhamidipati D, Shukla G, Sharma D, et al
    Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000537.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. HE Q, Zhang L, Zhang B, Shi X, et al
    Diagnostic accuracy of (13)N-ammonia PET, (11)C-methionine PET and (18)F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma.
    BMC Cancer. 2019;19:332.
    PubMed     Text format     Abstract available

  5. KOPER-LENKIEWICZ OM, Kaminska J, Milewska A, Sawicki K, et al
    Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor.
    BMC Cancer. 2019;19:319.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  6. JAMES Z, Leach PA, Hayhurst C
    Is 30-day readmission an accurate measure of morbidity in cranial meningioma surgery?
    Br J Neurosurg. 2019 Apr 10:1-4. doi: 10.1080/02688697.2019.1600658.
    PubMed     Text format     Abstract available


    Clin Neuropathol

  7. CAR M, Steblaj S, Mitrovic G, Dolenc-Strazar Z, et al
    Corticosteroid-induced immunodeficiency in a patient with gliomatosis cerebri: Are corticosteroids indicated in all brain tumors?
    Clin Neuropathol. 2019 Apr 9. pii: 18252. doi: 10.5414/NP301167.
    PubMed     Text format     Abstract available

  8. HABERLER C, Reiniger L, Rajnai H, Kalev O, et al
    Case of the month 1-2019: CNS high-grade neuroepithelial tumor with BCOR alteration.
    Clin Neuropathol. 2019;38:4-7.
    PubMed     Text format    


    Int J Cancer

  9. WANG Y, Xia Y, Hu K, Zeng M, et al
    MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32321.
    PubMed     Text format     Abstract available

  10. OSTROM QT, Egan KM, Nabors LB, Gerke T, et al
    Glioma risk associated with extent of estimated European genetic ancestry in African-Americans and Hispanics.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32318.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  11. HUGHES RT, Masters AH, McTyre ER, Farris MK, et al
    Initial SRS for patients with 5-15 brain metastases: results of a multi-institutional experience.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30613.
    PubMed     Text format     Abstract available


    J Neurooncol

  12. MEHTA GU, Ding D, Gupta A, Kano H, et al
    Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study.
    J Neurooncol. 2018;138:519-525.
    PubMed     Text format     Abstract available

  13. KEPE V, Scafoglio C, Liu J, Yong WH, et al
    Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.
    J Neurooncol. 2018;138:557-569.
    PubMed     Text format     Abstract available

  14. BEIGI M, Ghasemi K, Mirzaghavami P, Khanmohammadi M, et al
    Malignancy probability map as a novel imaging biomarker to predict malignancy distribution: employing MRS in GBM patients.
    J Neurooncol. 2018;138:619-625.
    PubMed     Text format     Abstract available

  15. LAI SF, Chen YH, Liang TH, Hsu CY, et al
    The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation.
    J Neurooncol. 2018;138:637-647.
    PubMed     Text format     Abstract available

  16. KARSY M, Akbari SH, Limbrick D, Leuthardt EC, et al
    Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort study.
    J Neurooncol. 2019 Apr 12. pii: 10.1007/s11060-019-03154.
    PubMed     Text format     Abstract available

  17. KIM MM, Speers C, Li P, Schipper M, et al
    Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
    J Neurooncol. 2019 Apr 11. pii: 10.1007/s11060-019-03166.
    PubMed     Text format     Abstract available

  18. HADJIPANAYIS CG, Stummer W, Sheehan JP
    5-ALA fluorescence-guided surgery of CNS tumors.
    J Neurooncol. 2019;141:477-478.
    PubMed     Text format    

  19. KANAMORI M, Kumabe T, Watanabe M, Chonan M, et al
    Indications for salvage surgery during treatment for intracranial germ cell tumors.
    J Neurooncol. 2018;138:601-607.
    PubMed     Text format     Abstract available


    Neuro Oncol

  20. ACHARYA S, Wu S, Ashford JM, Tinkle CL, et al
    Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study.
    Neuro Oncol. 2019 Apr 12. pii: 5447930. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. HOSSAIN JA, Latif MA, Ystaas LAR, Ninzima S, et al
    Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma.
    Neuro Oncol. 2019 Apr 8. pii: 5431345. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. MARISETTY AL, Lu L, Veo BL, Liu B, et al
    REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
    Neuro Oncol. 2019 Apr 6. pii: 5430241. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  23. FADHLULLAH SFB, Halim NBA, Yeo JYT, Ho RLY, et al
    Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0809.
    PubMed     Text format     Abstract available


    Pediatr Hematol Oncol

  24. DAS A, Ghosh P, Zameer L, Ramprasad VL, et al
    Simultaneous diagnosis of unilateral retinoblastoma and contralateral optic pathway glioma in a child with neurofibromatosis type 1.
    Pediatr Hematol Oncol. 2019 Apr 9:1-4. doi: 10.1080/08880018.2019.1591550.
    PubMed     Text format    

  25. CARCELLER F, Jerome NP, Fowkes LA, Khabra K, et al
    Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas.
    Pediatr Hematol Oncol. 2019 Apr 12:1-10. doi: 10.1080/08880018.2019.1592267.
    PubMed     Text format     Abstract available


    PLoS One

  26. JENSEN-KONDERING U, Helle M, Lindner T, Jansen O, et al
    Non-invasive qualitative and semiquantitative presurgical investigation of the feeding vasculature to intracranial meningiomas using superselective arterial spin labeling.
    PLoS One. 2019;14:e0215145.
    PubMed     Text format     Abstract available

  27. PERDOMO-PANTOJA A, Mejia-Perez SI, Reynoso-Noveron N, Gomez-Flores-Ramos L, et al
    Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
    PLoS One. 2018;13:e0206590.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: